ArticleOncotarget2016

Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay.

Maria Schwaederle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.